V Baccolini1, G Migliara2, C Isonne2, B Dorelli2, L C Barone2, D Giannini2, D Marotta2, M Marte2, E Mazzalai2, F Alessandri3, F Pugliese3,4, G Ceccarelli2, C De Vito2, C Marzuillo2, M De Giusti2, P Villari2. 1. Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185, Rome, Italy. valentina.baccolini@uniroma1.it. 2. Department of Public Health and Infectious Diseases, Sapienza University of Rome, Piazzale Aldo Moro 5, 00185, Rome, Italy. 3. Department of Anaesthesia and Intensive Care Medicine, Umberto I Teaching Hospital, Sapienza University of Rome, Rome, Italy. 4. Department of General and Specialist Surgery "P. Stefanini", Sapienza University of Rome, Rome, Italy.
Abstract
BACKGROUND: During the intensive care units' (ICUs) reorganization that was forced by the COVID-19 emergency, attention to traditional infection control measures may have been reduced. Nevertheless, evidence on the effect of the COVID-19 pandemic on healthcare-associated infections (HAIs) is still limited and mixed. In this study, we estimated the pandemic impact on HAI incidence and investigated the HAI type occurring in COVID-19 patients. METHODS: Patients admitted to the main ICU of the Umberto I teaching hospital of Rome from March 1st and April 4th 2020 were compared with patients hospitalized in 2019. We assessed the association of risk factors and time-to-first event through multivariable Fine and Grey's regression models, that consider the competitive risk of death on the development of HAI (Model 1) or device related-HAI (dr-HAI, Model 2) and provide estimates of the sub-distribution hazard ratio (SHR) and its associated confidence interval (CI). A subgroup analysis was performed on the 2020 cohort. RESULTS: Data from 104 patients were retrieved. Overall, 59 HAIs were recorded, 32 of which occurred in the COVID-19 group. Patients admitted in 2020 were found to be positively associated with both HAI and dr-HAI onset (SHR: 2.66, 95% CI 1.31-5.38, and SHR: 10.0, 95% CI 1.84-54.41, respectively). Despite being not confirmed at the multivariable analysis, a greater proportion of dr-HAIs seemed to occur in COVID-19 patients, especially ventilator-associated pneumonia, and catheter-related urinary tract infections. CONCLUSIONS: We observed an increase in the incidence of patients with HAIs, especially dr-HAIs, mainly sustained by COVID-19 patients. A greater susceptibility of these patients to device-related infections was hypothesized, but further studies are needed.
BACKGROUND: During the intensive care units' (ICUs) reorganization that was forced by the COVID-19 emergency, attention to traditional infection control measures may have been reduced. Nevertheless, evidence on the effect of the COVID-19 pandemic on healthcare-associated infections (HAIs) is still limited and mixed. In this study, we estimated the pandemic impact on HAI incidence and investigated the HAI type occurring in COVID-19patients. METHODS:Patients admitted to the main ICU of the Umberto I teaching hospital of Rome from March 1st and April 4th 2020 were compared with patients hospitalized in 2019. We assessed the association of risk factors and time-to-first event through multivariable Fine and Grey's regression models, that consider the competitive risk of death on the development of HAI (Model 1) or device related-HAI (dr-HAI, Model 2) and provide estimates of the sub-distribution hazard ratio (SHR) and its associated confidence interval (CI). A subgroup analysis was performed on the 2020 cohort. RESULTS: Data from 104 patients were retrieved. Overall, 59 HAIs were recorded, 32 of which occurred in the COVID-19 group. Patients admitted in 2020 were found to be positively associated with both HAI and dr-HAI onset (SHR: 2.66, 95% CI 1.31-5.38, and SHR: 10.0, 95% CI 1.84-54.41, respectively). Despite being not confirmed at the multivariable analysis, a greater proportion of dr-HAIs seemed to occur in COVID-19patients, especially ventilator-associated pneumonia, and catheter-related urinary tract infections. CONCLUSIONS: We observed an increase in the incidence of patients with HAIs, especially dr-HAIs, mainly sustained by COVID-19patients. A greater susceptibility of these patients to device-related infections was hypothesized, but further studies are needed.
Entities:
Keywords:
COVID-19; Devices-related infections; Healthcare-associated infection; Intensive care unit; SARS-CoV-2
Authors: Timothy M Rawson; Luke S P Moore; Nina Zhu; Nishanthy Ranganathan; Keira Skolimowska; Mark Gilchrist; Giovanni Satta; Graham Cooke; Alison Holmes Journal: Clin Infect Dis Date: 2020-12-03 Impact factor: 9.079
Authors: G Migliara; C Di Paolo; D Barbato; V Baccolini; C Salerno; A Nardi; F Alessandri; A Giordano; D Tufi; L Marinelli; A Cottarelli; M De Giusti; C Marzuillo; C De Vito; G Antonelli; M Venditti; G Tellan; M V Ranieri; P Villari Journal: Ann Ig Date: 2019 Sep-Oct
Authors: A Sturdy; M Basarab; M Cotter; K Hager; D Shakespeare; N Shah; P Randall; D Spray; A Arnold Journal: J Hosp Infect Date: 2020-06-23 Impact factor: 3.926
Authors: R Amarsy; G R Pean de Ponfilly; H A Benmansour; H Jacquier; E E Cambau; B Mégarbane Journal: Med Mal Infect Date: 2020-05-21 Impact factor: 2.152
Authors: Naveed Ahmed; Madiha Khan; Waqas Saleem; Mohmed Isaqali Karobari; Roshan Noor Mohamed; Artak Heboyan; Ali A Rabaan; Abbas Al Mutair; Saad Alhumaid; Salman A Alsadiq; Ahmed S Bueid; Eman Y Santali; Jeehan H Alestad Journal: Antibiotics (Basel) Date: 2022-02-19
Authors: Claudia Isonne; Valentina Baccolini; Giuseppe Migliara; Mariateresa Ceparano; Francesco Alessandri; Giancarlo Ceccarelli; Guglielmo Tellan; Francesco Pugliese; Maria De Giusti; Corrado De Vito; Carolina Marzuillo; Paolo Villari; Lavinia Camilla Barone; Dara Giannini; Daniela Marotta; Mattia Marte; Elena Mazzalai; Irma Germani; Arianna Bellini; Andrea Bongiovanni; Marta Castellani; Ludovica D'Agostino; Andrea De Giorgi; Chiara De Marchi; Elisa Mazzeo; Shadi Orlandi; Matteo Piattoli; Eleonora Ricci; Leonardo Maria Siena; Alessandro Territo; Stefano Zanni Journal: J Clin Med Date: 2022-03-07 Impact factor: 4.241
Authors: Iulia Bogdan; Cosmin Citu; Felix Bratosin; Daniel Malita; Ioan Romosan; Camelia Vidita Gurban; Adrian Vasile Bota; Mirela Turaiche; Melania Lavinia Bratu; Ciprian Nicolae Pilut; Iosif Marincu Journal: Antibiotics (Basel) Date: 2022-03-24